Innovative Approaches to Large-Scale Biologics Manufacturing | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Innovative Approaches to Large-Scale Biologics Manufacturing

Kevin Sharp (Business Development, Samsung Biologics)

Location: Insight Brief Theater

Date: Wednesday, May 1

Time: 12:30pm - 1:15pm

Track: Insight Briefing

Vault Recording: TBD

In the cost competitive environment of biopharmaceuticals, manufacturing costs are a key component to maintaining an edge in the market. Large-scale, stainless steel manufacturing, along with innovation in facility design provide cost advantages to biopharmaceutical companies. Furthermore, the increase in global biosimilar approvals and continued pressure from pricing policies further enhance the need for controlling manufacturing costs. Learn how manufacturing excellence, combined with state-of-the-art facilities and technology are advancing the biopharma industry. A live, guided tour of Samsung Biologics’ world-class facility via telepresence technology is also included.

Key takeaways from this session:
• Innovative facility design concepts within the most competitive biologics manufacturing plant
• Benefits of large-scale, stainless steel manufacturing to drive down operational costs
• Integration of state-of-the-art technology to streamline biologics manufacturing
• Live tour of the world’s largest single CMO plant